(Q46115260)

19 December 2017

title

Major achievements in hepatocellular carcinoma (English)

1 reference

19 December 2017

author

Jordi Bruix

series ordinal

1

1 reference

19 December 2017

Josep M. Llovet

series ordinal

2

1 reference

19 December 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

19 December 2017

published in

The Lancet

1 reference

19 December 2017

volume

373

1 reference

19 December 2017

page(s)

614-616

1 reference

19 December 2017

issue

9664

1 reference

19 December 2017

cites work

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Molecular targeted therapies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

Pivotal role of mTOR signaling in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960381-0

7 January 2021

10.1016/S0140-6736(09)60381-0

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19231618

1 reference

19 December 2017